Abstract: The subject matter described herein includes computational methods, systems and non-transitory computer readable media for de-novo drug discovery, which is based on deep learning and reinforcement learning techniques. The subject matter described herein allows generating chemical compounds with desired properties. Two deep neural networks—generative and predictive, represent the general workflow. The process of training consists of two stages. During the first stage, both models are trained separately with supervised learning algorithms, and during the second stage, models are trained jointly with reinforcement learning approach. In this study, we conduct a computational experiment, which demonstrates the efficiency of proposed strategy to maximize, minimize or impose a desired range to a property. We also thoroughly evaluate our models with quantitative approaches and provide visualization and interpretation of internal representation vectors for both predictive and generative models.

Abstract: The present invention is directed to compounds useful in the treatment of diseases associated with prenylation of proteins and pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising same, and to methods for inhibiting protein prenylation in an organism using the same.